<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8" />
<title>FragmentFeature xref</title>
<link type="text/css" rel="stylesheet" href="../../../../../stylesheet.css" />
</head>
<body>
<div id="overview"><a href="../../../../../../apidocs/org/biopax/paxtools/model/level3/FragmentFeature.html">View Javadoc</a></div><pre>
<a class="jxr_linenumber" name="L1" href="#L1">1</a>   <strong class="jxr_keyword">package</strong> org.biopax.paxtools.model.level3;
<a class="jxr_linenumber" name="L2" href="#L2">2</a>   
<a class="jxr_linenumber" name="L3" href="#L3">3</a>   <em class="jxr_javadoccomment">/**</em>
<a class="jxr_linenumber" name="L4" href="#L4">4</a>   <em class="jxr_javadoccomment"> * Definition: An entity feature that represents the resulting physical entity subsequent to a cleavage or</em>
<a class="jxr_linenumber" name="L5" href="#L5">5</a>   <em class="jxr_javadoccomment"> * degradation event.</em>
<a class="jxr_linenumber" name="L6" href="#L6">6</a>   <em class="jxr_javadoccomment"> *</em>
<a class="jxr_linenumber" name="L7" href="#L7">7</a>   <em class="jxr_javadoccomment"> * Usage: Fragment Feature can be used to cover multiple types of modfications to the sequence of the physical</em>
<a class="jxr_linenumber" name="L8" href="#L8">8</a>   <em class="jxr_javadoccomment"> * entity:</em>
<a class="jxr_linenumber" name="L9" href="#L9">9</a>   <em class="jxr_javadoccomment"> * &lt;ul&gt;</em>
<a class="jxr_linenumber" name="L10" href="#L10">10</a>  <em class="jxr_javadoccomment"> * &lt;li&gt;    A protein with a single cleavage site that converts the protein into two fragments (e.g. pro-insulin</em>
<a class="jxr_linenumber" name="L11" href="#L11">11</a>  <em class="jxr_javadoccomment"> * converted to insulin and C-peptide). TODO: CV term for sequence fragment?  PSI-MI CV term for cleavage site?</em>
<a class="jxr_linenumber" name="L12" href="#L12">12</a>  <em class="jxr_javadoccomment"> * &lt;li&gt;    A protein with two cleavage sites that removes an internal sequence e.g. an intein i.e. ABC -&amp;gt; A</em>
<a class="jxr_linenumber" name="L13" href="#L13">13</a>  <em class="jxr_javadoccomment"> * &lt;li&gt;    Cleavage of a circular sequence e.g. a plasmid.</em>
<a class="jxr_linenumber" name="L14" href="#L14">14</a>  <em class="jxr_javadoccomment"> * &lt;/ul&gt;</em>
<a class="jxr_linenumber" name="L15" href="#L15">15</a>  <em class="jxr_javadoccomment"> * In the case of removal ( e.g. intron)  the fragment that is *removed* is specified in the feature location</em>
<a class="jxr_linenumber" name="L16" href="#L16">16</a>  <em class="jxr_javadoccomment"> * property. In the case of a "cut" (e.g. restriction enzyme cut site) the location of the cut is specified instead.</em>
<a class="jxr_linenumber" name="L17" href="#L17">17</a>  <em class="jxr_javadoccomment"> * Examples: Insulin Hormone</em>
<a class="jxr_linenumber" name="L18" href="#L18">18</a>  <em class="jxr_javadoccomment"> */</em>
<a class="jxr_linenumber" name="L19" href="#L19">19</a>  <strong class="jxr_keyword">public</strong> <strong class="jxr_keyword">interface</strong> <a href="../../../../../org/biopax/paxtools/model/level3/FragmentFeature.html">FragmentFeature</a> <strong class="jxr_keyword">extends</strong> <a href="../../../../../org/biopax/paxtools/model/level3/EntityFeature.html">EntityFeature</a>
<a class="jxr_linenumber" name="L20" href="#L20">20</a>  {
<a class="jxr_linenumber" name="L21" href="#L21">21</a>  
<a class="jxr_linenumber" name="L22" href="#L22">22</a>  }
</pre>
<hr/>
<div id="footer">Copyright &#169; 2018 <a href="http://www.biopax.org">BioPAX</a>. All rights reserved.</div>
</body>
</html>
